Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001062993-23-003477 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-02-14	2023-02-10	COLL	Tupper Colleen	EVP, CFO	A - Grant	$0.00	+57.6K	147.9K	+64%	$0
M	2023-02-14	2023-02-10	COLL	Tupper Colleen	EVP, CFO	F - Tax	$26.75	-10.9K	137.1K	-7%	-$290.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-10	A	A	45,045	$0.00	135,349	D	—	—	(F1) Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
2	Common	Common Stock	2023-02-10	A	A	12,565	—	147,914	D	—	—	(F2) Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 12,565 performance share units granted in the issuer's three prior fiscal years.
3	Common	Common Stock	2023-02-10	F	D	6,967	$26.75	140,947	D	—	—	(F3) Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
4	Common	Common Stock	2023-02-10	F	D	3,887	$26.75	137,060	D	—	—	(F4) Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.